Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science (DHREAMS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00950118 |
Recruitment Status :
Recruiting
First Posted : July 31, 2009
Last Update Posted : November 8, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The goal of this study is to identify genes that convey susceptibility to congenital diaphragmatic hernia in humans. The identification of such genes, and examination of their structure and function, will enable a delineation of molecular pathogenesis and, ultimately, prevention or treatment of congenital diaphragmatic hernia. There are many different possible modes of inheritance for congenital anomalies, including autosomal dominant, autosomal recessive, and multifactorial. Multi-factorial inheritance is responsible for many common medical disorders, including hypertension, myocardial infarction, diabetes and cancer. This type of inheritance pattern appears to involve environmental factors as well as a combination of genetic variations that together can predispose to or produce congenital anomalies, such as congenital diaphragmatic hernia.
Our study is designed to establish a small, well-defined genetic resource consisting of 1) Nuclear families suitable for linkage analysis by parametric,non-parametric (e.g. sib pairs, TDT) and association techniques, 2) Individuals with congenital diaphragmatic hernia who can be directly screened for allelic variation in candidate genes, and 3) Individuals who can serve as controls (are unaffected by congenital diaphragmatic hernia). Neonates and their families will be collected from homogenous and heterogeneous populations. By characterizing diverse populations, it should be possible to increase the likelihood of demonstration of genetic variation in selected candidate genes that can then be used in association and linkage studies in individual subjects with congenital diaphragmatic hernia.
Condition or disease |
---|
Congenital Diaphragmatic Hernia |
Congenital diaphragmatic hernia (CDH) is a birth defect that occurs when the diaphragm (thin sheet of muscle that separates the abdomen from the chest) does not form properly. When an opening is present in the diaphragm, organs that are normally in the abdomen can be pushed (herniated) through the opening and be present in the chest. Currently little is known about why this birth defect occurs.
Through this study ""Molecular Genetic Analysis of Congenital Diaphragmatic Hernia" the investigators hope to learn more about whether certain genes contribute to CDH. Genes are the instructions or blueprints for our bodies. They tell our bodies how to grow and develop. Sometimes when a mistake occurs in one or more of our genes our body does not develop properly and this can lead to a CDH. The investigators hope that the information gained through studying the genes of children with CDH and their parents, will lead to significant advances in the diagnosis, prognosis, prevention, and treatment of this disease.
Study Type : | Observational |
Estimated Enrollment : | 3000 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science |
Study Start Date : | June 2005 |
Estimated Primary Completion Date : | November 2025 |
Estimated Study Completion Date : | November 2025 |

Group/Cohort |
---|
Congenital Diaphragmatic Hernia (CDH)
Humans affected with congenital diaphragmatic hernia (CDH)
|
Unaffected
Healthy family members of individuals affected with congenital diaphragmatic hernia (CDH)
|
- Percentage of patients with a genetic diagnosis [ Time Frame: 5 years ]DNA samples from patients will be analyzed for underlying genetic causes.
- Developmental outcomes at 2 and 5 years of age [ Time Frame: 1 exam at 2 year and 1 exam at 5 years ]Formal Developmental outcome measures
- Percentage of patients with pulmonary hypertension [ Time Frame: 5 years ]pulmonary hypertension measured by echocardiogram
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Children/neonates with an unrepaired congenital diaphragmatic hernia
Children/neonates with a reparied congenital diaphragmatic hernia
Women who are pregnant with a fetus diagnosed with congenital diaphragmatic hernia
Individuals with a family history of congenital diaphragmatic hernia
Inclusion Criteria:
- All individuals affected with a congenital diaphragmatic hernia (CDH), or with a family history of a CDH
Exclusion Criteria:
- Individuals with no personal history of a CDH or family history of a family member affected with congenital diaphragmatic hernia

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00950118
Contact: Julia Wynn, MS | 212-305-6987 | jw2500@columbia.edu | |
Contact: Becca Hernan, MS | 212-317-6503 | rh2813@cumc.columbia.edu |
United States, Illinois | |
Rush Hospital | Recruiting |
Chicago, Illinois, United States | |
Contact: Mindy Li, MD | |
Contact: Alexa Hart, MS, CGC | |
United States, Michigan | |
University of Michigan/ CS Mott Children's Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48167-5245 | |
Contact: George Mychalisa, MD, MS 734-763-2072 mychalis@med.umich.edu | |
Contact: Jeannie Kreutzman, RN, MSN 734-763-2072 jkreutzm@med.umich.edu | |
Principal Investigator: George Mychalisa, MD, MS | |
United States, Missouri | |
Washington University Medical Center/ St. Louis Children's Hospital | Recruiting |
Saint Louis, Missouri, United States, 63110 | |
Contact: Karen Lukas, RN 314-454-6022 lukask@wudosis.wustl.edu | |
Principal Investigator: Brad Warner, MD | |
United States, Nebraska | |
Children's Hospital of Omaha/ University of Nebraska | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Kenneth Azarow, MD 402-955-7400 kazarow@childrensomaha.org | |
Contact: Sheila Horak, APRN shorak@childrensomaha.org | |
Principal Investigator: Brad Warner, MD | |
United States, New York | |
Northwell Health | Recruiting |
Manhasset, New York, United States, 11030 | |
Contact: Samuel Soffer, MD ssoffer@nhsh.edu | |
Principal Investigator: Samuel Soffer, MD | |
Morgan Stanley Children's Hospital of New York- Presbyterian (Columbia University Medical Center) | Recruiting |
New York, New York, United States, 10032 | |
Contact: Julia Wynn, MS 212-305-6987 jw2500@columbia.edu | |
Contact: Wendy Chung, MD, PhD 212-851-5313 wkc15@columbia.edu | |
Principal Investigator: Wendy Chung, MD, PhD | |
Principal Investigator: Marc Arkovitz, MD | |
New York University, Hassenfeld Children's Hospital at NYU Langone Health | Recruiting |
New York, New York, United States | |
Contact: Jason Fisher, MD | |
Contact: Elizabeth Jehle | |
United States, Ohio | |
Cincinnati Children's Hospital and Medical Center/ University of Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45229 | |
Contact: Trish Burns, BSN 513-803-0745 trish.burns@cchmc.org | |
Principal Investigator: Foong Yen Lim, MD | |
United States, Oregon | |
Oregon Health & Science University, Doernbecher Children's Hospital | Recruiting |
Portland, Oregon, United States, 97239 | |
Contact: Brandy Gonzalez, RN gonzalbr@ohsu.edu | |
Contact: Ken Azarow, MD azarow@ohsu.edu | |
United States, Pennsylvania | |
Children's Hospital of Pittsburgh/ University of Pittsburgh | Completed |
Pittsburgh, Pennsylvania, United States, 15213 | |
United States, Tennessee | |
Monroe Carrell Jr Children's Hospital at Vanderbilt | Recruiting |
Nashville, Tennessee, United States, 37232 | |
Contact: Dai H Chung, MD 615-936-1050 dai.chung@vanderbilt.edu | |
Contact: Mary Dabrowiak 615-936-1050 mary.dabrowiak@Vanderbilt.Edu | |
Principal Investigator: Dai H Chung, MD | |
United States, Texas | |
UT Southwestern Medical Center, Children's Health, Dallas | Recruiting |
Dallas, Texas, United States, 75235 | |
Contact: David Schindel, MD 214-456-6040 David.Schindel@childrens.com | |
United States, Wisconsin | |
Medical College of Wisconsin | Completed |
Milwaukee, Wisconsin, United States, 53226 | |
Egypt | |
Cairo University Hospital | Recruiting |
Cairo, Egypt | |
Contact: Mahmoud Elfiky, MD 201001557755 drmelfiky@gmail.com | |
Principal Investigator: Mahmoud Elfiky, MD |
Principal Investigator: | Wendy Chung, MD, PhD | Columbia University |
Publications:
Responsible Party: | Columbia University |
ClinicalTrials.gov Identifier: | NCT00950118 |
Other Study ID Numbers: |
AAAB2063 R01HD057036 ( U.S. NIH Grant/Contract ) |
First Posted: | July 31, 2009 Key Record Dates |
Last Update Posted: | November 8, 2022 |
Last Verified: | November 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Congenital Diaphragmatic Hernia (CDH) Genes Genetic Genetic testing |
exome sequencing genome sequencing RNAseq |
Hernias, Diaphragmatic, Congenital Hernia Hernia, Diaphragmatic |
Pathological Conditions, Anatomical Internal Hernia Congenital Abnormalities |